# Cardiotoxicity of Adjuvant Trastuzumab

> **NCT00858039** · — · COMPLETED · sponsor: **Royal Prince Alfred Hospital, Sydney, Australia** · enrollment: 220 (actual)

## Conditions studied

- Breast Neoplasms
- Heart Failure

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00858039
- **Lead sponsor:** Royal Prince Alfred Hospital, Sydney, Australia
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2013-07
- **Final completion:** 2014-06
- **Target enrollment:** 220 (ACTUAL)
- **Last updated:** 2014-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00858039

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00858039, "Cardiotoxicity of Adjuvant Trastuzumab". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT00858039. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*